| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bc1d3b38e2676154e3d4bd6a4e3e300 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 |
| filingDate |
2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e00bba5e9fc7c8df5febfb86e48c64c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6a440683ef22c3d54098257f5875f9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4b126eb9928881407ab60eed80f9dea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7af530c91645b81507842c76eec0a571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28bd8163a1d28a03d83d38b181b807fd |
| publicationDate |
2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SG-11201807616R-A |
| titleOfInvention |
Proliferative agent for faecalibacterium |
| abstract |
[Problem] To provide a substance and method that are capable of effectively inducing proliferation of Faecalibacterium, thereby contributing to the prevention and treatment of diseases such as intestinal inflammation. [Solution] A proliferative agent for Faecalibacterium, comprising 1-kestose as an active ingredient. In accordance with the present invention, proliferation of Faecalibacterium can be effectively induced both in vitro and in vivo. In particular, it is possible to simply and effectively increase in vivo proliferation of Faecalibacterium in humans and animals, with almost no concerns regarding side effects or safety. It is also possible to prevent or treat intestinal inflammation by increasing in vivo proliferation of Faecalibacterium in humans and animals. |
| priorityDate |
2016-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |